RxDoctor Payments Data

Samuel Kellner, DPM

Foot & Ankle Surgery · Waterbury, CTNPI 1386164077

Payments from drug & device makers

What this record shows

This record is dominated by education: $5,430 of the $8,001 with a category attached, or 67.9%. Kairos Surgical Inc accounts for 69.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $2,847 and has fallen 90.3% since, to $276 in 2025.

$8,001in general payments, 2019–2025

Across 75 payments — averaging $106.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$6K
  • Smith+Nephew$675
  • Stryker$592
  • Organogenesis Inc.$361
  • Orthofix Medical, Inc.$185
  • Kerecis Limited$138
  • plus $518 from 13 others

What the payments were for

  • Speaking & faculty fees$1191%
  • Travel & lodging$4215%
  • Food & beverage$2,03125%
  • Education$5,43068%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,001 in reported general payments places this provider in the 80th percentile of 89 foot & ankle surgery providers in Connecticut.

See all foot & ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$137,902
Medicare patients
429
Services billed
2,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole14$18,941
Ammonium Lactate13$266
Cefadroxil24$229
Ciclopirox19$203
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$125
Methylprednisolone16$114
Meloxicam28$29

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →